MB

Mala Bhandary

Active Director Director DIN 00752028
DIN 00752028 First appointment Nov 1993 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 1993
Shareholding value •••• Premium profile

About Mala Bhandary

Data last updated:

Mala Bhandary is a Director at Biomedix Optotechnik And Devices Private Limited (since 1993). The company operates in Healthcare. Biomedix Optotechnik And Devices Private Limited reported revenue of ₹152 Cr (FY 2025).

DIN 00752028
Primary Designation Director
Industry Healthcare
First Appointment 25 Nov 1993
Oldest Company Age 32 yrs
Largest company Biomedix Optotechnik And Devices Private Limited · ₹152 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Nov 19931993₹152 Cr (FY 2025)Active

Board colleagues of Mala Bhandary

Directorship timeline

Open interactive timeline →
Biomedix Optotechnik And Devices Private Limited
Premium access

Shareholding and investment profile for Mala Bhandary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mala Bhandary

Mala Bhandary currently holds 1 directorship: Biomedix Optotechnik And Devices Private Limited (Director, since 25 Nov 1993, revenue ₹152 Cr (FY 2025)).

Mala Bhandary was first appointed on 25 Nov 1993 as Director at Biomedix Optotechnik And Devices Private Limited.

The current boards of Mala Bhandary's companies include Menal Krishna Ranjan Bhandary (Biomedix Optotechnik And Devices Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available